EC Number   |
Application |
Reference |
|---|
   3.4.24.35 | diagnostics |
circulating concentrations of MMP-9 may be a marker helping in the diagnosis and prognosis of cardiovascular and neoplastic diseases |
683114 |
| 3.4.24.35 | diagnostics |
gelatinase B expression as a prognostic factor in patients with stage II/III rectal carcinoma treated by postoperative adjuvant therapy, overview |
683037 |
| 3.4.24.35 | diagnostics |
in patients with clinical signs of meningitis, but without cerebrospinal fluid pleocytosis, enzyme and MMP-8, MMP-13 are highly sensitive markers for intrathecal inflammation |
670396 |
| 3.4.24.35 | diagnostics |
matrix metalloproteinase-9 expression in glioma is an independent prognostic factor of patients, which might be a potential diagnostic and therapeutic target of astrocytic glioma |
734590 |
| 3.4.24.35 | diagnostics |
MMP-9 expression is an independent and significant factor for prediction of a poor prognosis in colorectal cancer |
683518 |
| 3.4.24.35 | diagnostics |
MMP-9 levels are useful in endometriosis diagnostics |
683485 |
| 3.4.24.35 | drug development |
MMP-9 is a target for therapeutic treatment |
683844 |
| 3.4.24.35 | drug development |
MMP-9 is a therapeutic target in autoimmune diseases, vascular pathologies, and cancer |
684069 |
| 3.4.24.35 | drug development |
MMP-9 is an attractive target for therapeutic intervention studies in mouse models |
718355 |
| 3.4.24.35 | medicine |
a positive correlation between MMP-9 values and gestational age is observed in normal pregnant women |
699186 |
